Porous Matrix Tissue Scaffold for Enhanced Nutrient Diffusion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing porous matrices used as tissue scaffolds, such as hydrogels and water-insoluble polymers, face challenges with poor diffusion properties, leading to inadequate nutrient and drug delivery, potential cell damage during cross-linking, and inefficient cell seeding, which can result in treatment failure and immune reactions.
Innovation Solution
A process for producing a porous matrix involving a first phase being brought into a fluid state, mixing with a second phase, and allowing it to solidify, allowing for pre-shaping before insertion, with optional cell seeding or recruitment of endogenous cells, using polymers like PLGA and growth factors to enhance tissue growth without immune rejection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Volume of moving object
If hydrogels are used as tissue scaffolds, then the cavity filling capability is improved, but the nutrient and drug diffusion properties deteriorate
Solution Approach 1:
The patent employs porous particles as the matrix material, which inherently possess interconnected pore structures that enable effective diffusion of nutrients, drugs, and waste products throughout the scaffold volume, resolving the diffusion limitation of solid hydrogels while maintaining cavity filling capability
Solution Approach 2:
The scaffold combines porous particles with a gel matrix to create a composite structure that integrates the cavity-filling properties of gels with the superior diffusion characteristics of porous materials, achieving both adequate volume occupation and effective mass transport
2Stability of the object's composition
If cross-linking methods are used to stabilise gels, then the structural stability is improved, but the cell viability deteriorates
Solution Approach 1:
The patent extracts the cross-linking step entirely from the gel stabilization process, relying instead on the inherent structural integrity of porous particles and their interparticle interactions to provide stability without exposing cells to harmful cross-linking agents or conditions
Solution Approach 2:
The scaffold utilizes biodegradable porous particles that provide temporary structural support during tissue regeneration, eliminating the need for permanent cross-linked structures and allowing natural tissue to replace the scaffold over time without long-term foreign body presence
3Shape
If water-insoluble polymers are processed to form porous structures, then the scaffold structure is improved, but the cell seeding efficiency deteriorates
Solution Approach 1:
The patent employs a slurry formulation that transforms the rigid porous particle structure into a dynamic, flowable suspension during cell seeding, allowing cells to be uniformly distributed throughout the matrix before the slurry sets, thereby achieving high seeding efficiency while maintaining the desired porous scaffold structure
Solution Approach 2:
The slurry acts as an intermediary medium that facilitates cell incorporation into the porous particle matrix, providing a vehicle for cell delivery that maintains cell viability during handling and enables uniform distribution without direct cell-contact manipulation that could damage cells
4Adaptability or versatility
If the matrix is shaped before insertion, then the adaptability to target tissue is improved, but the processing complexity deteriorates
Solution Approach 1:
The patent performs preliminary shaping of the porous particle slurry to match the target tissue geometry before insertion, allowing the scaffold to be pre-customized for specific anatomical sites while maintaining processing simplicity through the use of moldable slurry formulations that can be easily shaped without complex manufacturing steps
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution enables effective tissue scaffolding with improved nutrient diffusion, reduced cell damage, and lower immune rejection risks, allowing for controlled tissue growth and regeneration without the need for immune suppressants, particularly beneficial for compromised patients.
Implementation Method 1
allowing the first phase to solidify or change state, with the second phase therein
Data Source
AI summary
A porous matrix suitable for use as a tissue scaffold is described. The matrix may be shaped before insertion into or at the target tissue site, or injected via a minimally invasive method. The matrix may be pre-seeded with cells of the target tissue or may be used to support growth of the local endogenous tissue. The matrix may contain growth factors or other pharmacologically acceptable moieties such as antibiotics.